ALLMedicine™ Hepatitis D Center

Nov 20th, 2020 - The role of low levels of HDV-RNA during and after interferon therapy of hepatitis D is unknown. We re-analyzed HDV RNA in 372 samples collected in the HIDIT-2 trial (Wedemeyer et al., Lancet Infectious Diseases 2019) with the Robogene assay (RA; ...

Nov 12th, 2020 - Although hepatitis D is believed to be an important medical problem in Africa and many areas of Asia, the geographical distribution and prevalence rates of infection with the hepatitis D virus (HDV) vary considerably, are often inconsistent and so...

Oct 7th, 2020 - The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown. A study of North American patients with hepatitis B (HBV) referred to the NIH...

Sep 30th, 2020 - As a result of the limited availability of in vivo models for hepatitis D virus (HDV), treatment options for HDV chronically infected patients are still scant. The discovery of sodium taurocholate cotransporting polypeptide (NTCP) as HDV entry rec...

Aug 7th, 2020 - In 1991, Peru launched the first vaccination program against hepatitis B in children aged under 5 years in the hyperendemic [hepatitis B virus (HBV) and hepatitis D virus (HDV)] province of Abancay. We conducted a cross-sectional study to determin...

Nov 20th, 2020 - The role of low levels of HDV-RNA during and after interferon therapy of hepatitis D is unknown. We re-analyzed HDV RNA in 372 samples collected in the HIDIT-2 trial (Wedemeyer et al., Lancet Infectious Diseases 2019) with the Robogene assay (RA; ...

Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Nov 12th, 2020 - Although hepatitis D is believed to be an important medical problem in Africa and many areas of Asia, the geographical distribution and prevalence rates of infection with the hepatitis D virus (HDV) vary considerably, are often inconsistent and so...

Oct 7th, 2020 - The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown. A study of North American patients with hepatitis B (HBV) referred to the NIH...

Sep 30th, 2020 - As a result of the limited availability of in vivo models for hepatitis D virus (HDV), treatment options for HDV chronically infected patients are still scant. The discovery of sodium taurocholate cotransporting polypeptide (NTCP) as HDV entry rec...

Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Dec 19th, 2019 - NEW YORK (Reuters Health) - Hepatitis delta virus (HDV) infection, which occurs only as a co-infection with acute hepatitis B (HBV) or a superinfection with chronic HBV, is associated with higher healthcare utilization and costs than HBV alone, a ...

Nov 8th, 2019 - BOSTON – For most patients with chronic hepatitis D virus (HDV) infection, combination therapy with lonafarnib, ritonavir, and peginterferon may significantly decrease viral loads, based on interim results from the phase IIa LIFT trial. After 6 mo.

Apr 19th, 2018 - What is the hepatitis virus? Well, the hepatitis virus invades liver cells and causes inflammation in the liver tissue. Five hepatitis viruses are recognized: hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E. They all have sligh...

Aug 1st, 2016 - In Reply: We thank Dr. Homler for bringing hepatitis D as a potential cause of acute liver failure to our attention.